Glaucoma Pathophysyology and Therapeutic Implication

Authors

  • Anda Maria Ster
  • Radu Anghel Popp
  • Felicia Maria Petrisor
  • Cristina Stan
  • Victor Ioan Pop

DOI:

https://doi.org/10.15386/cjmed-295

Keywords:

primary open angle glaucoma, genetic risk factors, oxidative stress, glutathion, nitric oxide

Abstract

Primary Open Angle Glaucoma(POAG) is a chronic, irreversible optic neuropathy leading to the progressive death of retinal ganglion cells, clinically observed as silent visual field loss along  with a decrease in colour and contrast sensitivity. Multiple pathogenic theories have been issued and some of them have proven their involvement in disease development: mechanical damage due to increased intraocular pressure, variable susceptibility of the optic nerve, mutation in specific nuclear genes, increased glutamate levels, alteration in nitric oxide (NO) metabolism, changes in the mitochondrial genome, vascular dysregulation, and toxic effects and oxidative damage cause by reactive oxygen species1.

The aim of this article is to highlight the pathogenic role of vascular dysregulation and reactive oxygen species in POAG with the further possibilities for prevention and gene therapy.

 

Author Biographies

Anda Maria Ster, Universitatea de Medicina si Farmacie Iuliu Hatieganu

Ophthalmology

Radu Anghel Popp, Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj

CATEDRA GENETICA MEDICALA

Felicia Maria Petrisor, Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj

CATEDRA DE GENETICA MEDICALA

Cristina Stan, Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj Spitalul Clinic Judetean de Urgenta Cluj

CATEDRA OFTALMOLOGIE

SECTIA CLINICA OFTALMOLOGIE

Victor Ioan Pop, Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj

CATEDRA DE GENETICA MEDICALA

Downloads

Additional Files

Published

2014-09-19

How to Cite

1.
Ster AM, Popp RA, Petrisor FM, Stan C, Pop VI. Glaucoma Pathophysyology and Therapeutic Implication. Med Pharm Rep [Internet]. 2014 Sep. 19 [cited 2025 Oct. 6];87(3):143-6. Available from: https://medpharmareports.com/index.php/mpr/article/view/295

Issue

Section

Reviews